Management of advanced prostate cancer: A systematic review of existing guidelines and recommendations.
Guidelines
Prostate cancer
Journal
Cancer treatment reviews
ISSN: 1532-1967
Titre abrégé: Cancer Treat Rev
Pays: Netherlands
ID NLM: 7502030
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
01
06
2018
revised:
28
11
2018
accepted:
30
11
2018
pubmed:
10
1
2019
medline:
6
2
2019
entrez:
10
1
2019
Statut:
ppublish
Résumé
The therapeutic landscape of advanced prostate cancer is continuously changing under the light of new available treatment options and the improved understanding of the molecular characteristics of the disease. The lack of high quality evidence regarding the sequencing of these treatments along with the earlier implementation of these therapeutic approaches during the course of the disease have created issues of dispute regarding the optimal treatment of patients with advanced prostate cancer. Therefore, we conducted a systematic review of the existing guidelines and recent randomized trials not included in these guidelines, and present a comprehensive analysis of the available treatment options in each of the stages of advanced prostate cancer, as well as the supportive treatments available for these patients.
Identifiants
pubmed: 30623865
pii: S0305-7372(18)30197-X
doi: 10.1016/j.ctrv.2018.11.005
pii:
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
54-61Informations de copyright
Copyright © 2018 Elsevier Ltd. All rights reserved.